Micro-X Limited (MX1.AX)
AUD 0.08
(7.79%)
AUD 0.08
(7.79%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 15.22 Million AUD | 1.45% |
| 2023 | 15 Million AUD | 67.28% |
| 2022 | 8.97 Million AUD | 137.87% |
| 2021 | 3.77 Million AUD | -11.29% |
| 2020 | 4.25 Million AUD | 120.15% |
| 2019 | 1.93 Million AUD | 20.16% |
| 2018 | 1.6 Million AUD | 143.85% |
| 2017 | 659 Thousand AUD | -26.12% |
| 2016 | 892 Thousand AUD | 1138.89% |
| 2015 | 72 Thousand AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 8.19 Million AUD | 0.0% |
| 2024 Q4 | 7.02 Million AUD | 0.0% |
| 2024 FY | 15.22 Million AUD | 1.45% |
| 2023 Q4 | 6.97 Million AUD | 0.0% |
| 2023 Q2 | 8.02 Million AUD | 0.0% |
| 2023 FY | 15 Million AUD | 67.28% |
| 2022 Q2 | 1.44 Million AUD | 0.0% |
| 2022 FY | 8.97 Million AUD | 137.87% |
| 2022 Q4 | 7.52 Million AUD | 0.0% |
| 2021 Q2 | 2.43 Million AUD | 0.0% |
| 2021 Q4 | 1.33 Million AUD | 0.0% |
| 2021 FY | 3.77 Million AUD | -11.29% |
| 2020 Q4 | 3.41 Million AUD | 0.0% |
| 2020 Q2 | 840 Thousand AUD | 0.0% |
| 2020 FY | 4.25 Million AUD | 120.15% |
| 2019 FY | 1.93 Million AUD | 20.16% |
| 2019 Q2 | 957 Thousand AUD | 0.0% |
| 2019 Q4 | 974 Thousand AUD | 0.0% |
| 2018 FY | 1.6 Million AUD | 143.85% |
| 2018 Q4 | 808 Thousand AUD | 0.0% |
| 2018 Q2 | 799 Thousand AUD | 0.0% |
| 2017 FY | 659 Thousand AUD | -26.12% |
| 2017 Q2 | 356 Thousand AUD | 0.0% |
| 2017 Q4 | 303 Thousand AUD | 0.0% |
| 2016 FY | 892 Thousand AUD | 1138.89% |
| 2016 Q4 | 610 Thousand AUD | 0.0% |
| 2016 Q2 | 282 Thousand AUD | 0.0% |
| 2015 Q3 | - AUD | -100.0% |
| 2015 FY | 72 Thousand AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2015 Q2 | 72 Thousand AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2013 FY | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | -305.46% |
| Adherium Limited | 840.98 Thousand AUD | -1710.027% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 75.974% |
| Atomo Diagnostics Limited | 4.08 Million AUD | -272.492% |
| Anteris Technologies Ltd | 4.11 Million AUD | -270.268% |
| Control Bionics Limited | 5.12 Million AUD | -196.905% |
| CardieX Limited | 10.9 Million AUD | -39.579% |
| Compumedics Limited | 49.71 Million AUD | 69.384% |
| Cochlear Limited | 2.25 Billion AUD | 99.326% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 3.178% |
| Cyclopharm Limited | 27.13 Million AUD | 43.912% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | -35.678% |
| Nova Eye Medical Limited | 23.32 Million AUD | 34.74% |
| HeraMED Limited | 402.89 Thousand AUD | -3678.137% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -2372.838% |
| ImpediMed Limited | 10.31 Million AUD | -47.514% |
| InhaleRx Limited | 1.2 Million AUD | -1164.237% |
| LBT Innovations Limited | 1.25 Million AUD | -1111.943% |
| Neurotech International Limited | 1963.00 AUD | -775345.746% |
| OncoSil Medical Limited | 1.56 Million AUD | -872.414% |
| PolyNovo Limited | 103.19 Million AUD | 85.249% |
| Respiri Limited | 456.91 Thousand AUD | -3231.48% |
| SomnoMed Limited | 91.65 Million AUD | 83.391% |
| Universal Biosensors, Inc. | 6.63 Million AUD | -129.495% |
| Uscom Limited | 3.72 Million AUD | -308.442% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | -75.571% |